Editor, – The authors of 'The quality and safety of traditional Chinese medicines' (Aust Prescr 2003;26:128-30) recommend the establishment of a quality testing system for Chinese herbs and their derivatives, in order to minimise mislabelling and identify undeclared components. This is based on the claims that the 'chemistry of herbal medicines is the foundation of their pharmacology', and that 'for most Chinese medicines the active components responsible for their pharmacological activities and clinical applications are not well defined'. The authors also point to the Chinese Medicine Registration Act in Victoria as an example of statutory regulation which will encourage the safe use of traditional Chinese medicines.
These recommendations are unexceptionable. However, these recommendations contain an irony, or a threat, depending on whether you subscribe to Western or Chinese medical systems. What is proposed is the application of Western scientific methods of analysis to Chinese medicines, in order to classify them as safe. In other words, the Chinese medical system, in order to survive in the dominant scientific culture, must subject itself to that culture's rules. This means that it cannot survive as a distinct and autonomous paradigm.
Mechanisms designed to ensure that Chinese medicines and practice (and any other traditional systems) continue to be recognised and respected, will ultimately ensure their demise.
Malcolm Parker
Associate Professor of Medical Ethics
School of Medicine
University of Queensland